The Cutaneous Lymphoma Foundation is embarking on a meaningful and collaborative leadership transition. Susan Thornton to Retire December 2026, Holly Priebe Named CEO-Elect July 2025

Warren, MI – August 1, 2025 – The Cutaneous Lymphoma Foundation (CLFoundation) is entering a new chapter with a carefully planned leadership transition. After more than a decade of dedicated service as CEO, Susan Thornton will retire on December 31, 2026. In preparation, the Board of Directors has unanimously elected Holly Priebe, the Foundation’s long-serving Chief Operating and Financial Officer, as the next CEO.

To ensure a smooth and collaborative transition, the CLFoundation Board agreed that Holly would begin serving as CEO-Elect on July 1, 2025. She will then step into the role of Co-CEO alongside Susan on January 1, 2026, before becoming the sole CEO on January 1, 2027 as Susan moves into serving as CEO-Emeritus.

This 18-month transition reflects the Foundation’s deep commitment to stability, continuity, and shared leadership. Susan and Holly have worked closely together for many years, and both are excited about what lies ahead—for themselves, the Foundation and the community they serve.
 

“This is not just a handoff—it’s a journey we are taking together,” said Susan. “I’m proud of what we’ve built and confident in Holly’s ability to lead the Foundation forward.”
Over the coming months, the Foundation will share opportunities to celebrate Susan’s remarkable legacy and engage with Holly as she prepares to lead the organization into the future.

Join us in congratulating both Susan and Holly on this exciting time for the Foundation.

For media inquiries, please contact:
Elizabeth Accad
Community Engagement Manager
248-644-9014